BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4364324)

  • 1. Growth and antigenic properties of a biopsy-derived Burkitt's lymphoma in thymus-less (nude) mice.
    Povlsen CO; Fialkow PJ; Klein E; Klein G; Rygaard J; Wiener F
    Int J Cancer; 1973 Jan; 11(1):30-9. PubMed ID: 4364324
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cell membrane receptor of cultured cells derived from nasopharyngeal carcinoma, Burkitt's lymphoma and infectious mononucleosis].
    Nishioka K; Tachibana T; Hirayama T; De Thé G; Klein G
    Nihon Ishikai Zasshi; 1971 Jun; 65(11):1398-406. PubMed ID: 4326465
    [No Abstract]   [Full Text] [Related]  

  • 3. Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA).
    Hayashi Y; Matsumura Y; Nishihira T; Watanabe I; Ohi R; Kasai M; Kumagai K; Kamada N
    Jpn J Exp Med; 1980 Dec; 50(6):423-34. PubMed ID: 6268866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An established Burkitt's lymphoma line with cell membrane IgG.
    Klein E; Nilsson K; Yefenoff E
    Clin Immunol Immunopathol; 1975 Mar; 3(4):575-83. PubMed ID: 163717
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological studies on a case of recurrent Burkitt's lymphoma during immune stimulant treatment.
    Gunvén P; Klein G; Henle W; Henle G; Rocchi G; Hewetson JF; Guerra A; Clifford P; Singh S; Demissie A; Svedmyr A
    Int J Cancer; 1973 Jul; 12(1):115-23. PubMed ID: 4364265
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor associated immune reactions in cancer patients.
    Klein G
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1163-5. PubMed ID: 4341124
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunity against DNA virus linked antigens in a human tumor (Burkitt's lymphoma)].
    Gunvén P
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):52-6. PubMed ID: 4145637
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological reactions to tumor-associated antigens in Burkitts lymphoma and other lymphomas.
    Herberman RB; McCoy JL; Levine PH
    Cancer Res; 1974 May; 34(5):1222-7. PubMed ID: 4366992
    [No Abstract]   [Full Text] [Related]  

  • 9. EVB-associated immune complexes and recurrent Burkitt's lymphoma.
    Gunven P; Klein G; Rosen A; Mukojima T
    IARC Sci Publ (1971); 1978; (24 Pt 2):875-82. PubMed ID: 221409
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.
    Gunvén P; Klein G; Henle G; Henle W; Clifford P
    Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656
    [No Abstract]   [Full Text] [Related]  

  • 11. Epstein-Barr virus in an American patient with Burkitt's lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB).
    Gravell M; Levine PH; McIntyre RF; Land VJ; Pagano JS
    J Natl Cancer Inst; 1976 Apr; 56(4):701-4. PubMed ID: 176407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Workshop in human tumor immunology.
    Oettgen HF; Bean MA; Klein G
    Cancer Res; 1972 Dec; 32(12):2845-53. PubMed ID: 4345410
    [No Abstract]   [Full Text] [Related]  

  • 13. Reactivity of radioiodinated serum antibody from Burkitt's lymphoma and nasopharyngeal carcinoma patients against culture lines derived from Bukrkitt's lymphoma.
    Inoue M; Klein G
    Clin Exp Immunol; 1970 Jul; 7(1):39-50. PubMed ID: 4320551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular reactions against Burkitt Lymphoma cells. I. Colony inhibition with effector cells from patients with Burkitt's lymphoma.
    Hewetson JF; Golub SH; Klien G; Singh S
    Int J Cancer; 1972 Jul; 10(1):142-9. PubMed ID: 4350508
    [No Abstract]   [Full Text] [Related]  

  • 15. Variant translocation in a non endemic case of Burkitt's lymphoma: t (8;22) in an Epstein--Barr virus negative tumour and in a derived cell line.
    Bertrand S; Berger R; Philip T; Bernheim A; Bryon PA; Bertoglio J; Doré JF; Brunat-Mentigny M; Lenoir GM
    Eur J Cancer (1965); 1981 May; 17(5):577-84. PubMed ID: 6271555
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellular reactions against Burkitt lymphoma cells. 3. Effector cell activity of leukocytes stimulated in vitro with autochthonous cultured lymphoma cells.
    Golub SH; Svedmyr EA; Hewetson JF; Klein G; Singh S
    Int J Cancer; 1972 Jul; 10(1):157-64. PubMed ID: 4122454
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies associated with Epstein-Barr virus in Burkitt's lymphoma during injections of BCG or irradiated autochthonous tumor cells.
    Gunvén P; Klein G; Onyango J; Henle G; Henle W; Clifford P; Singh S; Demissie A; Svedmyr A
    J Natl Cancer Inst; 1973 Jul; 51(1):45-56. PubMed ID: 4352753
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune complexes associated with neoplasia: presence of Epstein-Barr virus antigen-antibody complexes in Burkitt's lymphoma.
    Oldstone MB; Theofilopoulos AN; Gunvén P; Klein G
    Intervirology; 1974; 4(5):292-302. PubMed ID: 4377147
    [No Abstract]   [Full Text] [Related]  

  • 19. Killer T cells in a Burkitt's lymphoma biopsy.
    Jondal M; Svedmyr E; Klein E; Singh S
    Nature; 1975 May; 255(5507):405-7. PubMed ID: 1079330
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems posed by the immunological properties common to Burkitt's lymphoma and cancer. Means of resolving them].
    De-Thé G
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):767-88. PubMed ID: 4340546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.